arrow
F

Fumiaki Ando

Institute of Science Tokyo
H指数:21
被引数:1,260

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

β-Lactams vs Fluoroquinolones for Empiric Treatment of Suspected Kidney Cyst Infection: A Nationwide Observational Study

β-内酰胺类与氟喹诺酮类用于疑似肾囊肿感染的经验性治疗:一项全国性观察研究

2026-10-230
OAAI
Multi-target phosphodiesterase inhibition overcomes adipose catecholamine resistance and ameliorates systemic lipotoxicity

多靶点磷酸二酯酶抑制克服脂肪组织儿茶酚胺抵抗并改善系统性脂毒性

2026-01-010
OAAI
A Human Kidney Tubuloid Model of Repeated Cisplatin-Induced Cellular Senescence and Fibrosis for Drug Screening

人肾小管样模型用于重复顺铂诱导的细胞衰老和纤维化药物筛选

2025-10-090
OAAI
Delayed Therapeutic Response to Oral Corticosteroids and Rituximab Leading to Dialysis Independence in a Patient with Treatment-resistant C3 Glomerulonephritis

对1例治疗抵抗性C3肾小球肾炎患者口服皮质类固醇和利妥昔单抗治疗反应延迟,最终实现透析独立。

2025-10-010
OAAI
iPSC-based drug discovery identified the Hippo signaling pathway as a therapeutic target in the fibrosis of NPHP1-deficient nephronophthisis

iPSC-based药物发现将Hippo信号通路确定为NPHP1缺陷型肾小管间质性肾炎的纤维化治疗靶点

2025-09-200
OAAI
Author's Reply: “Associations Between Dietary Potassium Intake From Different Food Sources and Hyperkalemia in Patients With Chronic Kidney Disease”

作者回复:“不同食物来源的膳食钾摄入量与慢性肾脏病患者高钾血症之间的关联”

2025-05-280
PRE
CFAP47 is Implicated in X-Linked Polycystic Kidney Disease

CFAP47与X连锁多囊肾病有关

2024-12-010
OAAI
ULK1-regulated AMP sensing by AMPK and its application for the treatment of chronic kidney disease

AMPK检测ULK1-regulated AMP及其在慢性肾脏病治疗中的应用

2024-11-010
OAAI
Associations Between Dietary Potassium Intake From Different Food Sources and Hyperkalemia in Patients With Chronic Kidney Disease

慢性肾脏病患者不同食物来源膳食钾摄入与高钾血症的关系

2024-11-011
PRE
Importance of IFT140 in Patients with Polycystic Kidney Disease Without a Family History

IFT140在无家族史的多囊肾患者中的重要性

2024-09-012
OAAI